ET
Insider
Elizabeth H.Z. Thompson
EVP, Head of Research & DevElizabeth H.Z. Thompson (EVP, Head of Research & Dev) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in ACADIA Pharmaceuticals Inc. (ACAD). The largest single filing was $431K of ACAD (16,508 sh × $26.13, as filed), executed Jul 30.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$431K
shares × price, as filed
Last traded
Jul 30
Filed Jul 31
Median ADV $49.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $431K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
ACADRecent filings
ACADSALE
ACADIA Pharmaceuticals Inc.
View filing →
$431K16,508 sh × $26.13
Exec Jul 30
Filed Jul 31 · 6:00 PM ET